Nasdaq dbtx.

Nov 2, 2022 · Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today ... Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...BOSTON, March 22, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine ...BOSTON, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

TARRYTOWN, N.Y. and BOSTON, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Decibel Therapeutics, Inc. (NASDAQ: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today …BOSTON, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has extended the research term of its collaboration with Decibel Therapeutics Inc (NASDAQ: DBTX) to discover and develop gene therapies for hearing loss.

Nov 27, 2023 · 5 analysts have issued 1 year price targets for Decibel Therapeutics' shares. Their DBTX share price targets range from $2.00 to $23.00. On average, they predict the company's share price to reach $8.45 in the next twelve months. This suggests a possible upside of 72.1% from the stock's current price. View analysts price targets for DBTX or ... Motley Fool Issues Rare Triple-Buy Alert. This Stock Could Be Like Buying Amazon for $3.19. Find real-time Symbol not found stock quotes, company profile, news and forecasts from CNN Business.

Decibel Therapeutics, Inc. (Nasdaq - DBTX) Under the terms of the Merger Agreement, Decibel will be acquired by Regeneron Pharmaceuticals, Inc. (Nasdaq - REGN). Decibel shareholders will receive ...Decibel Therapeutics (NASDAQ:DBTX) has a recorded net income of -$63.01 million. DBTX has generated -$2.53 earnings per share over the last four quarters. What is Decibel Therapeutics's EPS forecast for next year?Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash ...A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. As at March 2023, Decibel Therapeutics had cash of US$88m and no debt ...

Decibel Therapeutics, Inc. (NASDAQ:DBTX) rose 13.5% to close at $4.88. Decibel Therapeutics recently reported top-line results from an interim analysis of its ongoing Phase 1b clinical trial of DB ...

Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash ...

BOSTON, May 17, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Decibel Therapeutics, Inc. Common Stock (DBTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Dropbox, Inc. (NASDAQ:DBX) is an American software company that operates a global collaboration platform. DBX has over 700 million registered users across about 180 countries, providing cloud storage, file synchronization, personal cloud, and client software. The software company has a large market cap, currently valued at $7.4 billion.Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash ...See the latest Decibel Therapeutics Inc Ordinary Shares stock price (NASDAQ:DBTX), related news, valuation, dividends and more to help you make your investing decisions.

BOSTON, March 21, 2023 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the appointment of Matthew Kapusta to its Board of Directors.“We are pleased to welcome …BOSTON, March 22, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Stock Symbol NASDAQ:DBTX ; Company Type For Profit; Contact Email [email protected]; Phone Number (617) 370-8701; Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction …Decibel intends to initiate the Phase 1/2 clinical trial of DB-OTO in the first half of 2023. BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage ...Mar 30, 2023 · BOSTON, March 30, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

BOSTON, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

Decibel intends to initiate the Phase 1/2 clinical trial of DB-OTO in the first half of 2023. BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage ...Dec 3, 2023 · Decibel Therapeutics (NASDAQ:DBTX) has a recorded net income of -$63.01 million. DBTX has generated -$2.53 earnings per share over the last four quarters. What is Decibel Therapeutics's EPS forecast for next year? (DBTX) reported a total revenue of $12.5 million in the first quarter of 2022 ... NASDAQ · NYSE · Blog. Need Help? [email protected]. Create your mobile categories ...BOSTON, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...The deal also has an additional contingent payment of $3.50 per share for DBTX stock if certain milestones are met. At the $4 price for DBTX stock, this offer represents a 43.3% premium over its ...Cash Position: As of March 31, 2023, cash, cash equivalents and available-for-sale securities were $87.9 million, compared to $104.6 million as of December 31, 2022. Research and Development ...Shareholders will receive $4.0000 and 1 share of DBTX^ for each share of DBTX previously held. ... NASDAQ. Copy link to clipboard. June 1, 2021. June 1, 2021.BOSTON, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage company developing treatments to restore and improve hearing and balance, presented preclinical data ...Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine ...

BOSTON, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

Mar 21, 2023 · BOSTON, March 21, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

BOSTON, May 17, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Decibel intends to initiate the Phase 1/2 clinical trial of DB-OTO in the first half of 2023. BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage ...If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...Decibel Therapeutics, Inc. (NASDAQ:DBTX) rose 13.5% to close at $4.88. Decibel Therapeutics recently reported top-line results from an interim analysis of its ongoing Phase 1b clinical trial of DB ...DermTech Inc (NASDAQ:DMTK) said its fourth-quarter revenues increased 33% year-over-year to $2.1 million. The net loss per share widened from 48 cents to 43 cents. The net loss per share widened ...DBTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Decibel Therapeutics, Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Decibel Therapeutics, Inc. (NASDAQ: DBTX) to Regeneron Pharmaceuticals, Inc. is fair to Decibel shareholders.BOSTON, March 18, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Dec 3, 2023 · Decibel Therapeutics (NASDAQ:DBTX) has a recorded net income of -$63.01 million. DBTX has generated -$2.53 earnings per share over the last four quarters. What is Decibel Therapeutics's EPS forecast for next year? Sep 4, 2023 · See the latest Decibel Therapeutics Inc Ordinary Shares stock price (NASDAQ:DBTX), related news, valuation, dividends and more to help you make your investing decisions. The stock was up 19.45% to $8.66 in after-hours trading. Pfizer-BioNTech COVID-19 Vaccine 100% Effective In Adolescent Population. Pfizer Inc. (NYSE:PFE) and its German partner BioNTech SE (NASDAQ ...

Find the latest Institutional Holdings data for Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com.BOSTON, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Instagram:https://instagram. xlc etfbest lng stocksrain industriesticker iemg Find the latest SEC Filings data for Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com. best health insurance for single maleis vsp worth it Decibel Therapeutics (NASDAQ:DBTX), which is focused on hearing loss treatments, is up 25% in Tuesday morning trading after Eli Lilly (NYSE:LLY) said it would acquire fellow hearing therapy ...Nov 8, 2021 · Find the latest press releases from Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com. exxon and mobil merger BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Decibel Therapeutics (NASDAQ: DBTX) stock is soaring higher on Wednesday after signing a deal with Regeneron Pharmaceuticals (NASDAQ: REGN ). …Find the latest dividend history for Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com.